3 Overlooked Biopharmas Insiders are Snapping Up

Roche Could Take a $500M Hit Over Patent Losses

Roche Could Take a $500M Hit Over Patent Losses

A look at three intriguing biotech stocks that are seeing big insider buying from top-ranked insiders right now.

Which hot healthcare stocks are corporate insiders snapping up right now? Tracking informative insider transactions is a smart way to find compelling investment opportunities. You are following the trades of people who truly know whether a company is poised for failure or success. And since it’s their personal money being invested, these trades speak volumes about what insiders are really thinking.

MORE ON THIS TOPIC